Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways.

BMC biology·2021
Same author

From commodity to money: The rise of silver coinage around the Ancient Mediterranean (sixth-first centuries bce).

Archaeometry·2021
Same author

Direct oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis.

Pharmacological research·2020
Same author

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis.

Thrombosis research·2020
Same author

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Respiratory research·2020
Same author

DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis.

Journal of thrombosis and thrombolysis·2020

Related Experiment Video

Updated: May 31, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Tiotropium improves walking endurance in COPD.

M-E Bédard1, C Brouillard, V Pepin

  • 1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725, Chemin Ste-Foy, Québec, G1V 4G5 Canada.

The European Respiratory Journal
|June 25, 2011
PubMed
Summary

Three weeks of tiotropium treatment significantly improved walking endurance and lung function in patients with chronic obstructive pulmonary disease (COPD). This enhancement in exercise capacity may be linked to improved ventilation and tidal volume.

Related Experiment Videos

Last Updated: May 31, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Area of Science:

  • Pulmonary Medicine
  • Clinical Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by airflow limitation.
  • Reduced exercise capacity, particularly walking ability, significantly impacts the quality of life for COPD patients.

Purpose of the Study:

  • To assess the efficacy of a 3-week tiotropium treatment on the walking capacity of COPD patients.
  • To evaluate the impact of tiotropium on pulmonary function and ventilatory parameters during exercise.

Main Methods:

  • A double-blind, parallel-group study involving 36 COPD patients randomized to tiotropium 18 μg once daily or placebo.
  • Assessment of pulmonary function (FEV(1), FVC, IC) and endurance shuttle walk performance before and after 3 weeks of treatment.
  • Monitoring of ventilatory parameters, including maximal ventilation and tidal volume, during exercise.

Main Results:

  • Tiotropium significantly increased walking endurance time by 128±141 s compared to placebo after 3 weeks (p=0.017).
  • Significant improvements in trough FEV(1), FVC, and IC were observed with tiotropium versus placebo.
  • Enhanced post-dose FEV(1), FVC, and IC responses were noted after the first dose and at 3 weeks.

Conclusions:

  • A 3-week tiotropium regimen effectively enhances walking endurance in COPD patients.
  • Improvements in lung function (FEV(1), FVC, IC) and exercise ventilation may underlie the observed gains in exercise capacity.